Company news
InnoCan Pharma Corporation news in 2026
InnoCan Pharma Corporation's news releases, calls and decks from 2026, newest first.
VALITIC(TM) Launches Direct-to-Consumer Website, Laying Groundwork for U.S. Holiday Campaign
October 8, 2026
VALITIC™ Launches Direct-to-Consumer Website, Laying Groundwork for U.S. Holiday Campaign
October 8, 2026
VALITIC™ Featured by BuzzFeed for "Magical Results," Further Strengthening Consumer Brand Momentum
October 1, 2026
Innocan Pharma Announces First Tranche Closing of Private Placement of Units
September 23, 2026
Innocan Pharma Announces Private Placement of Units
September 9, 2026
Innocan Pharma Announces Second Quarter Fiscal year 2026 Results, With Revenue of US$5.25M (CAD 7.3M)
August 31, 2026
Over 100,000 Positive Verified Customer Reviews Reflect Growing Consumer Trust
August 5, 2026
Valitic Surpasses 2 Million Trusted Customers, Marking a Major Milestone in Its Consumer Wellness Growth
July 29, 2026
Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M
May 27, 2026
Innocan Pharma LPT-CBD is featured in Pain Medicine News
May 6, 2026
Innocan Pharma Announces Closing of Additional Debenture
April 6, 2026
Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest
March 31, 2026
Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M
March 31, 2026
Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest
March 16, 2026
Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest
March 11, 2026
FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time
February 27, 2026
Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs
February 9, 2026
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
January 27, 2026